Please enter the email address you used to register, then we will send you a link to choose a new password
CLDX: 50% | Celldex Therapeutics shares are trading higher after the company announced data from its phase 2 trial treating urticaria refractory.
OGI: 47% | Organigram shares are trading higher after the company announced a C$124.6 million investment from BAT and the creation of "Jupiter" strategic investment pool.
PKX: 19% | Shares of South Korea ADRs, ETFs Rise Following Government Ban On Short Selling Through First Half of Next Year
Posted In: CLDX OGI PKX